Röhm is launching two new medical products in its Cyrolite portfolio of materials at the co-located Plastec West and Medical Design & Manufacturing (MD&M) West event in Anaheim this week.
Cyrolite G-20 CP is a polymethyl methacrylate (PMMA)–based copolymer for injection molding and extrusion of UV-light protective medical applications. Cyrolite G-20 CP ensures integrity of photosensitive substances such as oncology drugs, antibiotics, and antifungal agents that require UV-light protection.
The material features:
- Low UV-light transmission <1.0% 260 - 480 nm.
- Excellent transmittance between 500 and 780 nm.
With outstanding processability and unique bonding properties, Cyrolite G-20 CP has five times the impact resistance of unmodified acrylics and high resistance to body fluids and other chemicals, according to Röhm.
Cyrolite MD zk6 acrylic polymer is an amorphous, impact-modified thermoplastic injection molding and extrusion compound based on PMMA for the medical device and diagnostics industry. High impact resistance and ductility/toughness make Cyrolite MD zk6 suited for applications like dialysis cassettes, test packs, filter housings, microfluidics, luers, tube connectors, IV catheter hubs, and Y sites.
The compound has three times the impact resistance of other medical-grade acrylics and features high light transmission with little haze, said Röhm.
The company is showcasing these products in booth 1389 at MD&M West/Plastec West in Anaheim, CA, from Feb. 7 to 9, 2023.